StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.50−0.13 (-7.67%)

Close on Nov 13, 2026Market cap $34.11MP/E –Yield –

BioHarvest Sciences operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -16.2%, against -27.7% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-16.2%+11.6
FY2024Dec 31, 2024-27.7%+50.9
FY2023Dec 31, 2023-78.6%–

More BioHarvest Sciences figures

See a number that looks wrong?